InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2022-12-08 00:00:00 ET · period of report 2022-12-07 · accession 0000898432-22-000658 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-08 2022-12-07 IRMD HAWKINS JAMES B Dir M - OptEx $28.56 +3,072 33.5K +10% +$87.7K
DM 2022-12-08 2022-12-07 IRMD HAWKINS JAMES B Dir M - OptEx $0.00 -3,072 1,036 -75% $0
D 2022-12-08 2022-12-07 IRMD HAWKINS JAMES B Dir A - Grant $0.00 +3,501 4,537 +338% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-07 M A 1,035 $28.56 34,562 D — —
2 Common Common Stock 2022-12-07 M A 2,037 $28.56 33,527 D — —
3 Derivative Restricted Stock Units 2022-12-07 M D 2,037 $0.00 0 D — · — to — 2,037 Common Stock (F1) Restricted Stock Units convert to common stock on a one-for-one basis. (F2) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2021. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
4 Derivative Restricted Stock Units 2022-12-07 M D 1,035 $0.00 1,036 D — · — to — 1,035 Common Stock (F1) Restricted Stock Units convert to common stock on a one-for-one basis. (F3) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2022. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
5 Derivative Restricted Stock Units 2022-12-07 A A 3,501 $0.00 4,537 D — · — to — 3,501 Common Stock (F1) Restricted Stock Units convert to common stock on a one-for-one basis. (F4) The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.